Skip to main content
Reuters

DOJ Enforcement Outlook in Health Care Compliance for 2025

March 18, 2025
Authors
Jaime L.M. Jones
Some predicted a drop in False Claims Act (”FCA”) enforcement during the first Trump administration, but setting aside a likely pandemic-related slowdown during 2020–2022, FCA cases — both DOJ-initiated and qui tam — during the early part of the first Trump administration were consistent with the volume in the later part of the Biden administration.
View Article

Contacts

Jones, Jaime L.M.
Partner

Capabilities

Suggested News & Insights

Bay Area General Counsel RoundtableThursday, September 24, 2026
Conferences
U.S. Department of Justice Announces Major Justice Manual Revisions on Sub-Regulatory Guidance and Dismissals of FCA Qui TamsSeptember 21, 2026
Original Source
U.S. Department of Justice Announces Major Justice Manual Revisions on Sub-Regulatory Guidance and Dismissals of False Claims Act Qui TamsSeptember 21, 2026
Healthcare Update
When the Meeting Minutes and the AI Transcript Don’t Match: Litigation Insights From Delaware ChancerySeptember 17, 2026
White Collar Watch
FDA and SEC Announce Coordination on Scrutiny of Public DisclosuresSeptember 16, 2026
White Collar Watch
DOJ Announces Largest Settlement Yet in Drive to Use the FCA to Target Alleged Employment DiscriminationSeptember 16, 2026
Original Source